Opening book details…
About this Medicine article
40 kDa peginterferon alfa-2A (PEGASYS®): efficacy and safety results from a phase II, randomized, actively controlled, multicenter study in the treatment of HBeAg positive chronic hepatitis B: Graham E Cooksley, Royal Brisbane Hospital, Herston, Queensland Australia; Teerha Piratvisuth, Songklanakarin Hospital, Songkla Thailand; Yuan-Jen Wang, Teipei Veterans General Hospital, Taipei Taiwan;… is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Elsevier BV; Wiley; Research Square (ISSN 0270-9139)
- Published
- 2001
- Language
- EN
- Field
- Medicine (Health Sciences)